D. Bond

发表

Comparison of neuropsychological effects of adjunctive risperidone or quetiapine in euthymic patients with bipolar I disorder

R. Lam, I. Torres, J. Kozicky, 2012, International clinical psychopharmacology.

Weight gain as a risk factor for progressive neurochemical abnormalities in first episode mania patients: a longitudinal magnetic resonance spectroscopy study

R. Lam, I. Torres, D. Bond, 2021, Psychological Medicine.

Relationship between frontostriatal morphology and executive function deficits in bipolar I disorder following a first manic episode: data from the Systematic Treatment Optimization Program for Early Mania (STOP‐EM)

W. Honer, R. Lam, T. Ha, 2013, Bipolar disorders.

Lower cognitive functioning as a predictor of weight gain in bipolar disorder: a 12‐month study

R. Lam, I. Torres, J. Kozicky, 2017, Acta psychiatrica Scandinavica.

Oxidative stress markers in bipolar disorder: a meta-analysis.

Benicio N Frey, B. Frey, F. Kapczinski, 2008, Journal of affective disorders.

Association of peripheral inflammation with body mass index and depressive relapse in bipolar disorder

R. Lam, I. Torres, J. Kozicky, 2016, Psychoneuroendocrinology.

Diagnosis and body mass index effects on hippocampal volumes and neurochemistry in bipolar disorder

W. Honer, R. Lam, I. Torres, 2017, Translational Psychiatry.

Serum epidermal growth factor, clinical illness course, and limbic brain volumes in early-stage bipolar disorder.

R. Lam, I. Torres, D. Bond, 2020, Journal of affective disorders.

Quantification of diet quality utilizing the rapid eating assessment for participants-shortened version in bipolar disorder: Implications for prospective depression and cardiometabolic studies.

M. Frye, M. Clark, S. McElroy, 2022, Journal of affective disorders.

Burden of Depression in Outpatient HIV-Infected adults in Sub-Saharan Africa; Systematic Review and Meta-analysis

S. Lofgren, N. Nakasujja, D. Boulware, 2019, AIDS and Behavior.

Expert consensus recommendations on the use of randomized clinical trials for drug approval in psychiatry- comparing trial designs

A. Meyer-Lindenberg, A. Nierenberg, S. Strejilevich, 2022, European Neuropsychopharmacology.

Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysis.

R. Lam, D. Bond, L. Yatham, 2008, The Journal of clinical psychiatry.

Pharmacologic Management of Bipolar-II Disorder

D. Bond, L. Yatham, 2008 .

Clinical features of bipolar spectrum with binge eating behaviour.

M. Frye, S. McElroy, J. Biernacka, 2016, Journal of affective disorders.

Differences in perceived life stress in bipolar I and II disorder: Implications for future epigenetic quantification

M. Frye, S. McElroy, J. Biernacka, 2022, Personalized Medicine in Psychiatry.

The hypothalamic-pituitary-adrenal axis in bipolar disorder

A. Young, D. Bond, 2007 .

Association of total peripheral inflammation with lower frontal and temporal lobe volumes in early-stage bipolar disorder: A proof-of-concept study.

W. Honer, R. Lam, I. Torres, 2022, Journal of affective disorders.

The effect of sertraline on depression and associations with persistent depression in survivors of HIV-related cryptococcal meningitis

S. Lofgren, N. Nakasujja, D. Boulware, 2021, Wellcome Open Research.

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder

J. Calabrese, M. Alda, T. Suppes, 2018, Bipolar disorders.

Trajectories of body mass index change in first episode of mania: 3-year data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).

R. Lam, I. Torres, Gang Wang, 2017, Journal of affective disorders.

A secondary analysis of depression outcomes from a randomized controlled trial of adjunctive sertraline for HIV-associated cryptococcal meningitis

S. Lofgren, N. Nakasujja, D. Boulware, 2022, Wellcome Open Research.

Mania secondary to focal brain lesions: implications for understanding the functional neuroanatomy of bipolar disorder

D. Bond, David Satzer, 2016, Bipolar disorders.

Oxcarbazepine in the Treatment of Bipolar Disorder: A Review

R. Lam, D. Bond, L. Yatham, 2006, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations

M. Alda, S. Kanba, R. Post, 2021, Bipolar disorders.

Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.

M. Alda, W. Nolen, S. Kennedy, 2013, Bipolar disorders.

Comparison of Demographic and Clinical Features of Bipolar Disorder in Persons of African and European Ancestry

M. Frye, C. Patten, S. McElroy, 2022, Journal of Racial and Ethnic Health Disparities.

Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder.

R. Lam, F. Kapczinski, A. Andreazza, 2009, The international journal of neuropsychopharmacology.

The International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.

J. Calabrese, J. Amsterdam, A. Young, 2013, The American journal of psychiatry.

Consensus on nomenclature for clinical staging models in bipolar disorder: A narrative review from the International Society for Bipolar Disorders (ISBD) Staging Task Force

M. Alda, Jorge R. C. Almeida, R. Post, 2021, Bipolar disorders.

A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes

R. Lam, M. Berlim, A. McGirr, 2014, Psychological Medicine.

Association of Cytomegalovirus and Toxoplasma gondii Antibody Titers With Bipolar Disorder.

R. Yolken, M. Frye, S. McElroy, 2019, JAMA psychiatry.

Relationship between cognitive functioning and 6-month clinical and functional outcome in patients with first manic episode bipolar I disorder

W. Honer, R. Lam, I. Torres, 2010, Psychological Medicine.

Neurocognitive functioning in patients with bipolar I disorder recently recovered from a first manic episode.

W. Honer, R. Lam, I. Torres, 2010, The Journal of clinical psychiatry.

Course and Outcome after the First Manic Episode in Patients with Bipolar Disorder: Prospective 12-Month Data from the Systematic Treatment Optimization Program for Early Mania Project

R. Lam, I. Torres, D. Bond, 2009, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

3-Nitrotyrosine and glutathione antioxidant system in patients in the early and late stages of bipolar disorder.

F. Kapczinski, C. Gonçalves, A. Andreazza, 2009, Journal of psychiatry & neuroscience : JPN.

Exploring hepsin functional genetic variation association with disease specific protein expression in bipolar disorder: Applications of a proteomic informed genomic approach.

M. Frye, R. Weinshilboum, S. McElroy, 2017, Journal of psychiatric research.

A longitudinal study of hippocampal volume in first episode psychosis and chronic schizophrenia

Patricia Desmond, Dennis Velakoulis, Christos Pantelis, 2001, Schizophrenia Research.

Efficacy of second generation antipsychotics in treating acute mixed episodes in bipolar disorder: a meta-analysis of placebo-controlled trials.

R. Lam, K. Fountoulakis, D. Bond, 2013, Journal of affective disorders.

Depot risperidone in the outpatient management of bipolar disorder: a 2-year study of 10 patients

D. Bond, L. Yatham, Rao N Malempati, 2008, International clinical psychopharmacology.

Depot antipsychotic medications in bipolar disorder: a review of the literature

L. Yatham, D. Bond, L. Yatham, 2007, Acta psychiatrica Scandinavica. Supplementum.

Assessment of Proteomic Measures Across Serious Psychiatric Illness.

S. Schulz, R. Kaldate, D. Bond, 2017, Clinical schizophrenia & related psychoses.

Neurobiological correlates of overweight and obesity in people with bipolar disorder

D. Bond, 2013 .

The association of weight gain with mood symptoms and functional outcomes following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).

R. Lam, I. Torres, D. Bond, 2010, Bipolar disorders.

Call to action regarding the vascular‐bipolar link: A report from the Vascular Task Force of the International Society for Bipolar Disorders

A. Fagiolini, S. McElroy, R. McIntyre, 2020, Bipolar disorders.

Weight gain as a predictor of frontal and temporal lobe volume loss in bipolar disorder: A prospective MRI study

W. Honer, R. Lam, I. Torres, 2018, Bipolar disorders.

Body Mass Index–Related Regional Gray and White Matter Volume Reductions in First-Episode Mania Patients

Tae Hyon Ha, William G. Honer, W. Honer, 2014, Biological Psychiatry.

The Association of Elevated Body Mass Index with Reduced Brain Volumes in First-Episode Mania

W. Honer, R. Lam, I. Torres, 2011, Biological Psychiatry.

Comprehensive Pharmacologic Management of Bipolar Depression

A. McGirr, D. Bond, 2014, Current Treatment Options in Psychiatry.

Comprehensive Pharmacologic Management of Bipolar

D. Bond, D. McGirr, 2014 .

Divalproex sodium versus placebo in the treatment of acute bipolar depression: a systematic review and meta-analysis.

R. Lam, D. Bond, L. Yatham, 2010, Journal of affective disorders.

12‐month longitudinal cognitive functioning in patients recently diagnosed with bipolar disorder

W. Honer, R. Lam, I. Torres, 2014, Bipolar disorders.

Causal pathways to social and occupational functioning in the first episode of schizophrenia: uncovering unmet treatment needs

Sisi Ma, S. Vinogradov, E. Kummerfeld, 2021, Psychological Medicine.

The relationship between clinical outcomes and quality of life in first‐episode mania: a longitudinal analysis

R. Lam, I. Torres, D. Bond, 2013, Bipolar disorders.

A systematic review and meta-analysis of randomized controlled trials of adjunctive ketamine in electroconvulsive therapy: efficacy and tolerability.

R. Lam, M. Berlim, A. McGirr, 2015, Journal of psychiatric research.

Weight gain, obesity, and metabolic indices following a first manic episode: prospective 12-month data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).

R. Lam, D. Bond, L. Yatham, 2010, Journal of affective disorders.

Clinical Phenotype of Tardive Dyskinesia in Bipolar Disorder

M. Frye, S. McElroy, J. Biernacka, 2022, Journal of clinical psychopharmacology.

Adjunctive ketamine in electroconvulsive therapy: Updated systematic review and meta-analysis

R. Lam, M. Berlim, A. McGirr, 2017, British Journal of Psychiatry.

The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid attention-deficit/hyperactivity disorder.

R. Lam, R. McIntyre, S. Beaulieu, 2012, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

Cognitive change in the year after a first manic episode: association between clinical outcome and cognitive performance early in the course of bipolar I disorder.

R. Lam, I. Torres, J. Kozicky, 2014, The Journal of clinical psychiatry.

Managing medical and psychiatric comorbidity in individuals with major depressive disorder and bipolar disorder.

R. Ramasubbu, R. McIntyre, V. Taylor, 2012, Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists.

Association of schizophrenia polygenic risk score with manic and depressive psychosis in bipolar disorder

M. Frye, S. McElroy, T. Rummans, 2018, Translational Psychiatry.

Prevalence and correlates of DSM-5 eating disorders in patients with bipolar disorder.

M. Frye, S. McElroy, J. Biernacka, 2016, Journal of affective disorders.

Oxcarbazepine in the treatment of bipolar disorder

R. Lam, D. Bond, L. Yatham, 2006 .

Inflammatory cytokines and cognitive functioning in early-stage bipolar I disorder.

I. Torres, D. Bond, L. Yatham, 2019, Journal of affective disorders.

Hippocampal neurochemical markers in bipolar disorder patients following the first-manic episode: A prospective 12-month proton magnetic resonance spectroscopy study

F. Kapczinski, J. Bücker, J. Kozicky, 2017, The Australian and New Zealand journal of psychiatry.

Optimal duration of risperidone or olanzapine adjunctive therapy to mood stabilizer following remission of a manic episode: A CANMAT randomized double-blind trial

R. Lam, J. Quevedo, R. Milev, 2015, Molecular Psychiatry.

Clinical and Genetic Correlates of Bipolar Disorder With Childhood-Onset Attention Deficit Disorder

M. Frye, S. McElroy, J. Biernacka, 2022, Frontiers in Psychiatry.

Neuroprogression and episode recurrence in bipolar I disorder: A study of gray matter volume changes in first‐episode mania and association with clinical outcome

Kamyar Keramatian, R. Lam, A. McGirr, 2016, Bipolar disorders.

Functional outcomes in first-episode patients with bipolar disorder: a prospective study from the Systematic Treatment Optimization Program for Early Mania project.

R. Lam, D. Bond, L. Yatham, 2009, Comprehensive psychiatry.

CME A Multidisciplinary First-Episode Psychosis Program

S. Schulz, D. Bond, Amy L. Silberschmidt, 2015 .

Brain glutamate levels measured by magnetic resonance spectroscopy in patients with bipolar disorder: a meta‐analysis

R. Lam, B. Lafer, D. Bond, 2012, Bipolar disorders.

Systematic review of neurocognition and occupational functioning in major depressive disorder

R. Lam, G. Iverson, D. Bond, 2013 .

Genetic variant in SLC1A2 is associated with elevated anterior cingulate cortex glutamate and lifetime history of rapid cycling

M. Frye, S. McElroy, J. Biernacka, 2019, Translational Psychiatry.

Relationship between body mass index and hippocampal glutamate/glutamine in bipolar disorder.

W. Honer, R. Lam, I. Torres, 2016, The British journal of psychiatry : the journal of mental science.

Neurocognitive Functioning in Overweight and Obese Patients with Bipolar Disorder: Data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM)

R. Lam, I. Torres, F. Kapczinski, 2014, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

Which Depressive Symptoms and Medication Side Effects Are Perceived by Patients as Interfering Most with Occupational Functioning?

R. Lam, D. Bond, L. Yatham, 2012, Depression research and treatment.

(13)C magnetic resonance spectroscopy and glutamate metabolism in mood disorders: current challenges, potential opportunities.

K. Lim, D. Bond, 2014, The American journal of psychiatry.

Childhood maltreatment and corpus callosum volume in recently diagnosed patients with bipolar I disorder: data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).

W. Honer, R. Lam, I. Torres, 2014, Journal of psychiatric research.

The impact of childhood trauma on cognitive functioning in patients recently recovered from a first manic episode: data from the Systematic Treatment Optimization Program for Early Mania (STOP-EM).

R. Lam, I. Torres, J. Bücker, 2013, Journal of affective disorders.

A Longitudinal Study of the Relationships Between Mood Symptoms, Body Mass Index, and Serum Adipokines in Bipolar Disorder.

R. Lam, I. Torres, J. Kozicky, 2017, Journal of Clinical Psychiatry.

S0033291721000544jra 3783..3791

R. Lam, I. Torres, D. Bond, 2022 .

Revising Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, criteria for the bipolar disorders: Phase I of the AREDOC project

M. Alda, J. Amsterdam, A. Young, 2018, The Australian and New Zealand journal of psychiatry.

Special review article Oxidative stress markers in bipolar disorder: A meta-analysis

B. Frey, F. Kapczinski, A. Andreazza, 2008 .

A Multidisciplinary First-Episode Psychosis Program

S. Schulz, D. Bond, Amy L. Silberschmidt, 2015 .

Bipolar II Disorder in Context: A Review of Its Epidemiology, Disability and Economic Burden

D. Bond, L. Yatham, T. Chakrabarty, 2019, Bipolar II Disorder.

Long-term efficacy of risperidone long-acting injectable in bipolar disorder with psychotic features: a prospective study of 3-year outcomes

D. Bond, L. Yatham, M. Kunz, 2011, International clinical psychopharmacology.

A Positron Emission Tomography Study of Norepinephrine Transporter Occupancy and Its Correlation with Symptom Response in Depressed Patients Treated with Quetiapine XR

V. Sossi, R. Lam, Yu-Shin Ding, 2017, The international journal of neuropsychopharmacology.

W. Honer, R. Lam, T. Ha, 2013, Bipolar disorders.

Duration of Adjunctive Antidepressant Maintenance in Bipolar I Depression.

R. Lam, B. Frey, Y. Ahn, 2023, The New England journal of medicine.

Arun Ravindran, Michael Berk, Roumen Milev, 2013, Bipolar disorders.

Neuroprogression and episode recurrence in bipolar I disorder: A study of gray matter volume changes in first‐episode mania and association with clinical outcome

Kamyar Keramatian, R. Lam, A. McGirr, 2016, Bipolar disorders.

The evolution of CANMAT Bipolar Disorder Guidelines: past, present, and future.

M. Alda, S. Kennedy, R. McIntyre, 2013, Bipolar disorders.

Exploring hepsin functional genetic variation association with disease specific protein expression in bipolar disorder: Applications of a proteomic informed genomic approach.

M. Frye, R. Weinshilboum, S. McElroy, 2017, Journal of psychiatric research.